These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 36138408)

  • 41. The usefulness of rapid point-of-care creatinine testing for the prevention of contrast-induced nephropathy in the emergency department.
    You JS; Chung YE; Park JW; Lee W; Lee HJ; Chung TN; Chung SP; Park I; Kim S
    Emerg Med J; 2013 Jul; 30(7):555-8. PubMed ID: 22833599
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluating chronic kidney disease in rural South Africa: comparing estimated glomerular filtration rate using point-of-care creatinine to iohexol measured GFR.
    Currin S; Gondwe M; Mayindi N; Chipungu S; Khoza B; Khambule L; Snyman T; Tollman S; Fabian J; George J;
    Clin Chem Lab Med; 2021 Jul; 59(8):1409-1420. PubMed ID: 33711217
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Usefulness of point-of-care testing in the treatment of diabetes in an underserved population.
    Leal S; Soto-Rowen M
    J Diabetes Sci Technol; 2009 Jul; 3(4):672-6. PubMed ID: 20144311
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Use of point-of-care testing and early assessment model reduces length of stay for ambulatory patients in an emergency department.
    Kankaanpää M; Raitakari M; Muukkonen L; Gustafsson S; Heitto M; Palomäki A; Suojanen K; Harjola VP
    Scand J Trauma Resusc Emerg Med; 2016 Oct; 24(1):125. PubMed ID: 27756354
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Performance evaluation of Hipee S2 point-of-care testing urine dipstick analyser: a cross-sectional study.
    Zhang Q; Wang G; Zong X; Sun J
    BMJ Open; 2022 Oct; 12(10):e063781. PubMed ID: 36302575
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Validation of an electrochemical sensor based on gold nanoparticles as a point-of-care test for quantitative determination of glycated hemoglobin.
    Boonprasert K; Tharavanij T; Pechyen C; Ponsanti K; Tangnorawich B; Viyanant V; Na-Bangchang K
    PLoS One; 2023; 18(6):e0276949. PubMed ID: 37384652
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy of Point-of-Care for INR Testing Compared to Standard Laboratory Methods at a Tertiary Care Hospital in Saudi Arabia.
    Bhat M; Abuzied Y; Fagih Z; Wani T; Gawan I; Andalay EM; AlSheef M
    Glob J Qual Saf Healthc; 2020 Aug; 3(3):98-104. PubMed ID: 37275600
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A comparison between point-of-care testing and venous glucose determination for the diagnosis of diabetes mellitus 6-12 weeks after gestational diabetes.
    Coetzee A; van de Vyver M; Hoffmann M; Hall DR; Mason D; Conradie M
    Diabet Med; 2019 May; 36(5):591-599. PubMed ID: 30663133
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Point-of-care creatinine testing for kidney function measurement prior to contrast-enhanced diagnostic imaging: evaluation of the performance of three systems for clinical utility.
    Snaith B; Harris MA; Shinkins B; Jordaan M; Messenger M; Lewington A
    Clin Chem Lab Med; 2018 Jul; 56(8):1269-1276. PubMed ID: 29672267
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Haemoglobin A1c: evaluation of a new HbA1c point-of-care analyser Bio-Rad in2it in comparison with the DCA 2000 and central laboratory analysers.
    Yeo CP; Tan CH; Jacob E
    Ann Clin Biochem; 2009 Sep; 46(Pt 5):373-6. PubMed ID: 19487414
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lactate POCT in mobile intensive care units for septic patients? A comparison of capillary blood method versus venous blood and plasma-based reference methods.
    Léguillier T; Jouffroy R; Boisson M; Boussaroque A; Chenevier-Gobeaux C; Chaabouni T; Vivien B; Nivet-Antoine V; Beaudeux JL
    Clin Biochem; 2018 May; 55():9-14. PubMed ID: 29522709
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Estimated glomerular filtration rate using a point of care measure of creatinine in patients with iohexol determinate GFR.
    Stojkovic V; Delanaye P; Collard G; Ferrante N; Le Goff C; Lutteri L; Cavalier E
    Clin Chim Acta; 2019 Dec; 499():123-127. PubMed ID: 31479650
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bringing the lab bench to the field: Point-of-care testing for enhancing health research and stakeholder engagement in rural/remote, indigenous, and resource-limited contexts.
    Madimenos FC; Gildner TE; Eick GN; Sugiyama LS; Snodgrass JJ
    Am J Hum Biol; 2022 Nov; 34(11):e23808. PubMed ID: 36166487
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Point of care testing for pediatric following up of hemoglobin A1C: Concern on product's property.
    Wiwanitkit V
    Diabetes Metab Syndr; 2011; 5(4):214-5. PubMed ID: 25572766
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Variation in Point-of-Care Testing of HbA1c in Diabetes Care in General Practice.
    Kristensen T; Waldorff FB; Nexøe J; Skovsgaard CV; Olsen KR
    Int J Environ Res Public Health; 2017 Nov; 14(11):. PubMed ID: 29120361
    [No Abstract]   [Full Text] [Related]  

  • 56. Point-of-care testing performed by healthcare professionals outside the hospital setting: consensus based recommendations from the IFCC Committee on Point-of-Care Testing (IFCC C-POCT).
    Khan AI; Pratumvinit B; Jacobs E; Kost GJ; Kary H; Balla J; Shaw J; Milevoj Kopcinovic L; Vaubourdolle M; Oliver P; Jarvis PRE; Pamidi P; Erasmus RT; O'Kelly R; Musaad S; Sandberg S
    Clin Chem Lab Med; 2023 Aug; 61(9):1572-1579. PubMed ID: 37267483
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A combined laboratory and field evaluation of the Cholestech LDX and CardioChek PA point-of-care testing lipid and glucose analysers.
    Whitehead SJ; Ford C; Gama R
    Ann Clin Biochem; 2014 Jan; 51(Pt 1):54-67. PubMed ID: 23880620
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of several point-of-care testing (POCT) glucometers with an established laboratory procedure for the diagnosis of type 2 diabetes using the discordance rate. A new statistical approach.
    Püntmann I; Wosniok W; Haeckel R
    Clin Chem Lab Med; 2003 Jun; 41(6):809-20. PubMed ID: 12880146
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Facilitators and barriers of the implementation of point-of-care devices for cardiometabolic diseases: a scoping review.
    Tenorio-Mucha J; Busta-Flores P; Lazo-Porras M; Vetter B; Safary E; Moran AE; Gupta R; Bernabé-Ortiz A
    BMC Health Serv Res; 2023 Apr; 23(1):412. PubMed ID: 37118750
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Point-of-care measurement of clozapine concentration using a finger-stick blood sample.
    Taylor D; Atkins M; Harland R; Baburina I; MacCabe JH; Salamone SJ; McGuire P
    J Psychopharmacol; 2021 Mar; 35(3):279-283. PubMed ID: 33579175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.